Abstract:Background: Renal Cell Carcinoma (RCC) is the most common type of kidney cancer (85%). 75% of the RCC cases involve conventional clear cell RCC (ccRCC). Approximately, 39% of late-stage patients (stage IV) are treated with chemotherapeutic agents. Phosphatidylinositol-3-kinase (PI3K) and Mitogen-Activated Protein Kinase Kinase (MEK)/extracellular signal-regulated kinase (ERK1/2) pathways are frequently activated in RCC. In addition, atypical PKCs (PKC-ί and PKC ζ) are overexpressed in most cancer cells, and they play a central role in tumor progression and the metastasis of different types of cancers. Our goal is to establish the role of aPKCs in the regulation of multiple key activated pathways in ccRCC. In this study, we also established a novel therapeutic regimen for dual inhibition of key activated pathways. Method: In this study, 786-0 and Caki-1 cells were studied and subjected to cell viability assay, western blot analysis, scratch & wound healing assay, transwell invasion assay, immunofluorescence, immunoprecipitation, flow cytometry, and quantitative real-time polymerase chain reaction. We used combination of PI3K inhibitor- Alpelisib (BYL719) and ICA-1 (a PKC-ι-specific 5-amino-1-2,3-dihydroxy-4-(methylcyclopentyl)-1H-imidazole-4-carboxamide). In addition to drug treatment, small interfering RNA (siRNA) technology was used to further confirm the experimental outcome of the drug treatment. Results: Our results suggest that treatment of ccRCC cells with a combination of ICA-1 (aPKC inhibitor) and BYL719 (PI3K inhibitor) downregulates PKC-ί and causes downstream inhibition of c-Myc. Inhibition of the PKCί also reduces activation of MEK/ERK1/2. It is observed that treatment with ICA-1 disrupts the level of the aPKC-Akt1 association. ICA-1 treatment also shows a reduced level of association between aPKC and c-Myc. The inhibition of aPKCs and downstream effector proteins by combination therapy is more pronounced compared to a single therapy. These effects contribute to reduced cell growth, and eventually, the induction of apoptosis. The decreased level of N-cadherin, p-vimentin, and vimentin and the increased level of E-cadherin confirm reduced malignancy. Conclusion: Therefore, implementing a combination of Alpelisib and a PKC-ι inhibitor is an effective approach to reducing cell proliferation, and invasion that eventually induces apoptosis and may be considered as a potential therapeutic option in ccRCC.

Downregulating PKC Δ Provides a PI3K/Akt-independent Survival Signal That Overcomes Apoptotic Signals Generated by C-Src Overexpression

Hypoxia Confers Protection Against Apoptosis Via the PI3K/Akt Pathway in Endothelial Progenitor Cells.

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

Downregulation Of Cypher Induces Apoptosis In Cardiomyocytes Via Akt/P38 Mapk Signaling Pathway

Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides

Down-Regulation Of Pkhd1 Induces Cell Apoptosis Through Pi3k And Nf-Kappa B Pathways

PKC Signal Amplification Suppresses Non-Small Cell Lung Cancer Growth by Promoting P21 Expression and Phosphorylation

Regulation of the Viability of Nf1 Deficient Cells by PKC Isoforms

PKC signaling prevents irradiation-induced apoptosis of primary human fibroblasts

Protein Kinase Cδ in Apoptosis: A Brief Overview

An Integrated PKD1-dependent Signaling Network Amplifies IRE1 Prosurvival Signaling

Knockdown of PKCε Expression Inhibits Growth, Induces Apoptosis and Decreases Invasiveness of Human Glioma Cells Partially Through Stat3

Protein Kinase C-Delta Mediates Down-Regulation of Heterogeneous Nuclear Ribonucleoprotein K Protein: Involvement in Apoptosis Induction

Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase

SDF-1α/CXCR4 Decreases Endothelial Progenitor Cells Apoptosis under Serum Deprivation by PI3K/Akt/eNOS Pathway

PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells.

Ctenopharyngodon idella PKZ facilitates cell apoptosis through phosphorylating eIF2α.

Dual inhibition of atypical PKC signaling and PI3K/Akt signaling dysregulates c-Myc to induce apoptosis in clear cell Renal Cell Carcinoma

Chronic Protein Kinase B (Pkb/c-Akt) Activation Leads to Apoptosis Induced by Oxidative Stress-Mediated Foxo3a Transcriptional Up-Regulation.

Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.

Abstract 4382: PKC-ι/ζ signaling is crucial for apoptosis/pyroptosis inhibition and invasiveness of glioblastoma cells through upregulation of β-catenin, PDK1/Akt1 and Smad cascades via 14-3-3